Literature DB >> 15861043

Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variants.

Jennifer S Mammen1, Heather E Kleiner, John DiGiovanni, Thomas R Sutter, Paul T Strickland.   

Abstract

OBJECTIVES: Coumarins are naturally occurring chemicals with potential as chemopreventive agents, several with known action on the cytochrome P450 1A family. We examined whether cytochrome P450 1B1 (CYP1B1) was inhibited by coumarins, whether such inhibition was competitive, and whether inhibition varied between common polymorphic variants of this enzyme.
METHODS: We tested the inhibition properties of four coumarins, bergamottin, isopimpinellin, isoimperatorin, and imperatorin in an assay for oxidation of (-)benzo[a]pyrene-7R-trans-7,8-dihyrodiol (B[a]P-7,8-diol) by CYP1B1 using yeast-microsome expressed enzymes. These assays were performed with wild-type enzyme and five single-amino acid polymorphic variants.
RESULTS: All four coumarins are competitive inhibitors of CYP1B1, with Ki values equal to 587, 11, 6 and 1 muM respectively. Inhibition parameters were consistent between five haplotypes of CYP1B1, three representing common haplotypes in Asians, African-Americans and European-Americans, and two with baseline kinetic parameters previously shown to be potentially different from wild-type.
CONCLUSIONS: Coumarins are capable of inhibiting carcinogen activation by CYP1B1 with varying potencies, and their efficacy as chemopreventive agents is not likely to be affected by polymorphism in this enzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861043     DOI: 10.1097/01213011-200503000-00007

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  6 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 2.  Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Authors:  Slobodan P Rendic; Frederick P Guengerich
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

Review 3.  Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.

Authors:  Tsutomu Shimada
Journal:  Toxicol Res       Date:  2017-04-15

4.  Machine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors.

Authors:  Baddipadige Raju; Gera Narendra; Himanshu Verma; Manoj Kumar; Bharti Sapra; Gurleen Kaur; Subheet Kumar Jain; Om Silakari
Journal:  ACS Omega       Date:  2022-08-31

5.  Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.

Authors:  Yusuf Y Deeni; Sally H Ibbotson; Julie A Woods; C Roland Wolf; Gillian Smith
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

6.  Electrochemical reduction of coumarins at a film-modified electrode and determination of their levels in essential oils and traditional Chinese herbal medicines.

Authors:  Lai-Hao Wang; Hsiu-Hua Liu
Journal:  Molecules       Date:  2009-09-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.